entertainment -WSS

entertainment

author：focus 2025-10-01 21:09:38 - browse：53629

Eli Lilly headquarters — Kristoffer Tripplaar/AP

SAN DIEGO – An experimental pill from Eli Lilly led to 14.7% weight loss on the highest dose in a 36-week trial, heating up the growing competition among drugmakers to develop an effective oral obesity therapy.

The mid-stage results for orforglipron match the estimates of 14-15% weight loss that Lilly gave in an investor call late last year. The full results, published Friday in the New England Journal of Medicine, were presented here to a packed conference room at the American Diabetes Association conference.

By the end of trial, the authors said, participants’ weight loss had not plateaued, suggesting potential for even greater weight loss over a longer treatment period.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Health officials lay out plans to cope with respiratory virus season

WSS

A clever new way to fix Medicaid and graduate medical education

How the drug

Biotech incubator Curie.Bio graduates its first startup

As obesity drug market grows, telehealth companies court payers

Can U.S. cancer drug shortages be fixed?

Trump to be booked at notorious Fulton County Jail at center of DOJ probe

explore

entertainment

Wikipedia

Supreme Court strikes down use of affirmative action

Free speech concerns arise in wake of journal editor Eisen's firing

Walensky prepares to leave CDC — and Congress — behind

Meadows told special counsel he could not recall Trump ever declassifying Mar

BioMarin wins approval for gene therapy to treat hemophilia A

Study: New antibiotic targets gonorrhea as well as last existing drug

Wildfire smoke exposes gaps in outdoor worker protections

Health officials lay out plans to cope with respiratory virus season

In age of alternative facts, a scholarly course on calling out crap

Listen: Vivek Ramaswamy's star turn & leaky drug data

explore

Free speech concerns arise in wake of journal editor Eisen's firing

STAT Executive Editor Rick Berke on STAT's 8th birthday

10 million people disenrolled from Medicaid over past six months

What past blockbusters can tell us about future of Wegovy and other weight loss medicines

DeSantis wants to import drugs. Biden’s FDA blasted his plan

Abortion clinic in Cancun will cater to Americans

hotspot

leisure time

focus

entertainment